# Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis

> **NCT06422000** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 75 (actual)

## Conditions studied

- Necrotizing Enterocolitis

## Interventions

- **DRUG:** Pentoxifylline
- **DRUG:** Probiotic Formula

## Key facts

- **NCT ID:** NCT06422000
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-30
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422000, "Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06422000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*